Assetmark, Inc Dynavax Technologies Corp Transaction History

Assetmark, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$7.08 - $12.09 $247 - $423	-35 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$8.14 - $13.28 $333 - $544	-41 Reduced 53.95%	35 $0
Q3 2018 Nov 13, 2018	SELL	$11.85 - $16.0 $82 - $112	-7 Reduced 8.43%	76 $1,000
Q2 2018 Aug 01, 2018	SELL	$15.15 - $20.75 $30 - $41	-2 Reduced 2.35%	83 $1,000
Q1 2018 May 16, 2018	BUY	$14.65 - $19.9 $234 - $318	16 Added 23.19%	85 $2,000
Q4 2017 Feb 13, 2018	BUY	$17.3 - $24.08 $1,193 - $1,661	69	69 $1,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.